Second Generation Long-acting Injectable Antipsychotics as a First-lineTreatment of First Episode Schizophrenia:Lights and Shadows
- Domenico De Berardis1,2,3*
- 1Department of Mental Health, Psychiatric Service of Diagnosis and Treatment, Hospital “G. Mazzini”, ASL 4 Teramo, Italy
- 2Department of Neuroscience, Imaging and Clinical Science, Chair of Psychiatry, University “G. D’Annunzio”, Chieti, Italy
- 3Polyedra Clinical Group, Teramo, Italy
*Corresponding Author:
Domenico De Berardis,
MD, PhD, National Health Service, Department of Mental Health, Psychiatric Service of Diagnosis and Treatment, “G. Mazzini” Hospital